Keosys Medical Imaging

Founded in 2001, Keosys has established itself as a leading full-service Imaging CRO focused on bringing high quality images and services to its customers. With over 15 years’ experience in medical imaging, Keosys helps pharmaceutical and biotechnology companies bring new drugs to market by leveraging imaging data in clinical trials. In addition to its leading proprietary cloud-based platform to centralize and analyze imaging data Keosys offers project management services and scientific expertise that allow sponsors to focus on their core business rather than operational bottlenecks and difficulties managing large complex data sets. Keosys has worked on more than 90 clinical trials and has centralized over 68 million DICOM images for 35,000 patients over the past 10 years. Keosys has a long track record working on Phase II and III trials in the oncology, neurology, and cardiology space and has long history managing trials in the fields of Molecular Imaging and Nuclear Medicine. Whether you are a large pharma or biotech company, a CRO, or an academic institution, Keosys will help you: - Enhance your imaging data quality and traceability - Improve your Return on Investment (ROI) - Allow earlier go/no-go decisions - Bring you more efficient image workflow and analysis The company is headquartered in France and has subsidiary in the United States (New York City) and Asia (Singapore). Specialties: Medical Imaging, Radiology, Nuclear Medicine, Clinical Trials, Oncology, Neurology, Autoimmune, MRI, PET/CT, SPECT/CT, Nuclear Medicine, and EORTC

show less